Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Mooberry

Showing results (91-100 of 120) with videos related to

Pageof 12
Sort By:
Breast Cancer Research and Treatment|June 24, 2019
Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtypeCorena V Grant, Chase M Carver, Shayne D Hastings, et al.
Journal of Medicinal Chemistry|October 24, 2008
Interrogating the bioactive pharmacophore of the latrunculin chemotype by investigating the metabolites of two taxonomically unrelated spongesTaro Amagata, Tyler A Johnson, Robert H Cichewicz, et al.
Journal of Natural Products|April 29, 2006
Lophocladines, bioactive alkaloids from the red alga Lophocladia spHarald Gross, Douglas E Goeger, Patrice Hills, et al.
Bioorganic & Medicinal Chemistry|January 22, 2013
Synthesis of N(4)-(substituted phenyl)-N(4)-alkyl/desalkyl-9H-pyrimido[4,5-b]indole-2,4-diamines and identification of new microtubule disrupting compounds that are effective against multidrug resistant cellsAleem Gangjee, Nilesh Zaware, Ravi Kumar Vyas Devambatla, et al.
Journal of Natural Products|October 6, 2020
CRISPR-Cas9 Genome-Wide Knockout Screen Identifies Mechanism of Selective Activity of Dehydrofalcarinol in Mesenchymal Stem-like Triple-Negative Breast Cancer CellsCorena V Grant, Shengxin Cai, April L Risinger, et al.
Journal of Medicinal Chemistry|May 24, 2016
Design, Synthesis, and Preclinical Evaluation of 4-Substituted-5-methyl-furo[2,3-d]pyrimidines as Microtubule Targeting Agents That Are Effective against Multidrug Resistant Cancer CellsRavi Kumar Vyas Devambatla, Ojas A Namjoshi, Shruti Choudhary, et al.
European Journal of Medicinal Chemistry|April 29, 2011
A novel class of trans-methylpyrazoline analogs of combretastatins: synthesis and in-vitro biological testingMegan Lee, Olivia Brockway, Armaan Dandavati, et al.
Molecular Pharmacology|December 15, 2015
Biological Characterization of an Improved Pyrrole-Based Colchicine Site Agent Identified through Structure-Based DesignCristina C Rohena, Nakul S Telang, Chenxiao Da, et al.
Marine Drugs|September 27, 2014
Didemnaketals f and g, new bioactive spiroketals from a red sea ascidian didemnum speciesLamiaa A Shaala, Diaa T A Youssef, Sabrin R M Ibrahim, et al.
Molecular Pharmacology|April 26, 2007
Identification and characterization of a new tubulin-binding tetrasubstituted brominated pyrroleSusan L Mooberry, Kimberly N Weiderhold, Sivanesan Dakshanamurthy, et al.
Pageof 12

Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Breast Cancer Research and Treatment|June 24, 2019
Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtypeCorena V Grant, Chase M Carver, Shayne D Hastings, et al.
Journal of Medicinal Chemistry|October 24, 2008
Interrogating the bioactive pharmacophore of the latrunculin chemotype by investigating the metabolites of two taxonomically unrelated spongesTaro Amagata, Tyler A Johnson, Robert H Cichewicz, et al.
Journal of Natural Products|April 29, 2006
Lophocladines, bioactive alkaloids from the red alga Lophocladia spHarald Gross, Douglas E Goeger, Patrice Hills, et al.
Bioorganic & Medicinal Chemistry|January 22, 2013
Synthesis of N(4)-(substituted phenyl)-N(4)-alkyl/desalkyl-9H-pyrimido[4,5-b]indole-2,4-diamines and identification of new microtubule disrupting compounds that are effective against multidrug resistant cellsAleem Gangjee, Nilesh Zaware, Ravi Kumar Vyas Devambatla, et al.
Journal of Natural Products|October 6, 2020
CRISPR-Cas9 Genome-Wide Knockout Screen Identifies Mechanism of Selective Activity of Dehydrofalcarinol in Mesenchymal Stem-like Triple-Negative Breast Cancer CellsCorena V Grant, Shengxin Cai, April L Risinger, et al.
Journal of Medicinal Chemistry|May 24, 2016
Design, Synthesis, and Preclinical Evaluation of 4-Substituted-5-methyl-furo[2,3-d]pyrimidines as Microtubule Targeting Agents That Are Effective against Multidrug Resistant Cancer CellsRavi Kumar Vyas Devambatla, Ojas A Namjoshi, Shruti Choudhary, et al.
European Journal of Medicinal Chemistry|April 29, 2011
A novel class of trans-methylpyrazoline analogs of combretastatins: synthesis and in-vitro biological testingMegan Lee, Olivia Brockway, Armaan Dandavati, et al.
Molecular Pharmacology|December 15, 2015
Biological Characterization of an Improved Pyrrole-Based Colchicine Site Agent Identified through Structure-Based DesignCristina C Rohena, Nakul S Telang, Chenxiao Da, et al.
Marine Drugs|September 27, 2014
Didemnaketals f and g, new bioactive spiroketals from a red sea ascidian didemnum speciesLamiaa A Shaala, Diaa T A Youssef, Sabrin R M Ibrahim, et al.
Molecular Pharmacology|April 26, 2007
Identification and characterization of a new tubulin-binding tetrasubstituted brominated pyrroleSusan L Mooberry, Kimberly N Weiderhold, Sivanesan Dakshanamurthy, et al.
Pageof 12